CASE REPORT
Anti-Yo Associated Paraneoplastic Cerebellar Degeneration in Ovarian Cancer: A Rare Case Report
Received Date : 02 Sep 2020
Accepted Date : 03 Dec 2020
Available Online : 02 Feb 2021
Yusuf İLHANa, Merve Çagla KORKMAZb, Ecem TAŞKIRAN GÜZELb, Khalida MAMMADOVAc,Sema SEZGİN GÖKSUa, Ali Murat TATLIa, Hasan Şenol COŞKUNa
aDepartment of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, TURKEY
bDepartment of Internal Medicine, Akdeniz University Faculty of Medicine, Antalya, TURKEY
cDepartment of Neurology, Akdeniz University Faculty of Medicine, Antalya, TURKEY
Doi: 10.37047/jos.2020-78768 - Article's Language: EN
J Oncol Sci. 2021;7(1):31-3
ABSTRACT
Paraneoplastic cerebellar degeneration (PCD) is a rare neurological complication in cancer, characterized by the rapid development
of cerebellar ataxia. It is mostly seen in gynecological cancers, breast cancer, and small cell lung cancer. Here, we present a case of
anti-Yo-associated PCD in an ovarian cancer patient. A recurrence in ovarian cancer was observed in this patient after the diagnosis of PCD.
Keywords: Paraneoplastic cerebellar degeneration; anti-Yo; ovarian cancer; relapse disease
REFERENCES
- Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol 2008; 7: 327-340. [Crossref]
- Fanous I, Dillon P. Paraneoplastic neurological complications of breast cancer. Exp Hematol Oncol. 2015;5:29. [Crossref] [PubMed] [PMC]
- Shams'ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 2003;126:1409-18. [Crossref] [PubMed]
- Mason WP, Graus F, Lang B, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain. 1997;120:1279-300. [Crossref] [PubMed]
- Croft PB, Wilkinson M. The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma. Brain 1965; 88: 427-434. [Crossref] [PubMed]
- Goldstein BH, Birk CL, Van Houten M, et al. Ovarian cancer and late onset paraneoplastic cerebellar degeneration. Arch Gynecol Obstet 2009; 280: 99- 101. [Crossref] [PubMed]
- Power DG, McVey GP, Delaney DW, et al. Papillary serous carcinomas of the uterine cervix and paraneoplastic cerebellar degeneration: a report of two cases. Acta Oncol 2008; 47: 1590- 3. [Crossref] [PubMed]
- Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-40. [Crossref] [PubMed] [PMC]
- Le May M, Dent S. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review. Curr Oncol. 2018;25(6):e585-e591. [Crossref] [PubMed] [PMC]
- Sakai K, Shirakawa T, Li Y, et al. Interaction of a paraneoplastic cerebellar degeneration-associated neuronal protein with the nuclear helix-loop-helix leucine zipper protein MRG X. Mol Cell Neurosci 2002; 19: 477-484. [Crossref] [PubMed]
- Jarius S, Wildemann B. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti‐Yo/CDR2, anti‐Nb/AP3B2, PCA‐2, anti‐Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation 2015; 12: 168. [Crossref] [PubMed] [PMC]
- Albert ML, Darnell JC, Bender A, et al. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 1998;4:1321-1324. [Crossref] [PubMed]
- Cao Y, Abbas J, Wu X, et al. Anti-Yo-positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature. Gynecol Oncol. 1999;75:178-183. [Crossref] [PubMed]
- de Beukelaar JW, Sillevis Smitt PA. Managing paraneoplastic neurological disorders. Oncologist 2006; 11: 292- 305. [Crossref] [PubMed]
JOURNAL of
EN